UNION KOREA PHARM Corrects Listing Date of 60M New Shares for Third-Party Allotment, Delayed by One Week
The listing date of 60 million new shares for the third-party allotment to Bukwang Pharmaceutical under the rehabilitation plan has been delayed by one week from July 22 to July 29, 2026, due to practical delays at the depository.
This correction is merely a schedule adjustment; all key terms such as the 60 million share issuance, 500 won issue price, 300 billion won proceeds, and the purpose of debt repayment remain unchanged.
Upon completion, the largest shareholder will change to Bukwang Pharmaceutical, resulting in approximately 75% dilution of existing shareholders' stakes.
[AI Summary]The one-week delay in the listing of UNION KOREA PHARM's new shares is a minor procedural issue with limited impact on shareholder value. However, the massive dilution from the 60 million share offering and the impending change in control remain significant risks.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)